January 3 – The COMET Trial: Rethinking Treatment for Low-Risk DCIS
August 1 – 2023 ASCO Highlights, Part 2: Treatment De-Escalation
July 6 – 2023 ASCO Highlights, Part 1: CDK4/6 Inhibitors
March 1 – February 9, 2023 FDA Oncologic Drugs Advisory Committee
February 1 – 2022 San Antonio Breast Cancer Symposium (Highlights – Part 2)
January 5 – 2022 San Antonio Breast Cancer Symposium (Highlights – Part 1)
September 30 – ESMO 2022 – Key Take-Aways in Breast Cancer
September 2 – FDA Approval of Enhertu in HER2 Low Advanced or Metastatic Breast Cancer
July 22 – ASCO 2022 – Key Take-Aways in Breast Cancer, Part 3: Breast Cancer Mortality Studies
July 7 – ASCO 2022 – Key Take-Aways in Breast Cancer, Part 2: The Paloma-2 Study
June 27 – ASCO 2022 – Key Take-Aways in Breast Cancer, Part 1: DESTINY-Breast 03 and DESTINY-Breast 04 Trials
February 11 – More Highlights from the 2021 San Antonio Breast Cancer Symposium
January 21 – Highlights from the 2021 San Antonio Breast Cancer Symposium
